Organizations
Conferences
Info & Opinion
December 3, 2008
News from Pharsight, TrialStat, NNIT, EmPower, Reagan-Udall Center.
Ranbaxy is planning to buy a contract research organization (CRO) that would be a component of a new R&D subsidiary. The CRO would be part of a partially owned R&D division to include Ranbaxy’s ongoing collaborative programs with GSK. Ranbaxy…
After linking five deaths to a defective defibrillator wire, Medtronic announced it would stop making the Sprint Fidelis lead. The company’s release doesn’t use the word “recall,” but the FDA’s statement does. Because of surgical complications, the wires should not…